-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Windtree Therapeutics Inc /De/ quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2023.
- Windtree Therapeutics Inc /De/ Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.75M, a 561% increase year-over-year.
- Windtree Therapeutics Inc /De/ Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $15.9M, a 6168% increase year-over-year.
- Windtree Therapeutics Inc /De/ annual Nonoperating Income (Expense) for 2023 was $306K, a 59.6% decline from 2022.
- Windtree Therapeutics Inc /De/ annual Nonoperating Income (Expense) for 2022 was $758K.
- Windtree Therapeutics Inc /De/ annual Nonoperating Income (Expense) for 2021 was -$343K, a 84.7% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)